PROCAN Drug Patent Profile
✉ Email this page to a colleague
When do Procan patents expire, and when can generic versions of Procan launch?
Procan is a drug marketed by Parke Davis, Parkedale, and King Pharms. and is included in eight NDAs.
The generic ingredient in PROCAN is procainamide hydrochloride. There are nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the procainamide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Procan
A generic version of PROCAN was approved as procainamide hydrochloride by INTL MEDICATION on July 31st, 1984.
Summary for PROCAN
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 72 |
Clinical Trials: | 1 |
Patent Applications: | 4,111 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROCAN at DailyMed |
Recent Clinical Trials for PROCAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Evan Adelstein, MD | N/A |
UPMC | N/A |
University of Pittsburgh | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for PROCAN
US Patents and Regulatory Information for PROCAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Parke Davis | PROCAN | procainamide hydrochloride | CAPSULE;ORAL | 085804-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Parkedale | PROCAN SR | procainamide hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 087510-001 | Apr 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Parke Davis | PROCAN SR | procainamide hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 086468-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |